Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBITDA: 2010-2025

Historic EBITDA for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $83.1 million.

  • Alkermes' EBITDA fell 13.79% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $337.3 million, marking a year-over-year decrease of 0.74%. This contributed to the annual value of $368.2 million for FY2024, which is 1.29% up from last year.
  • According to the latest figures from Q3 2025, Alkermes' EBITDA is $83.1 million, which was down 4.65% from $87.2 million recorded in Q2 2025.
  • Over the past 5 years, Alkermes' EBITDA peaked at $237.8 million during Q2 2023, and registered a low of -$66.3 million during Q3 2022.
  • For the 3-year period, Alkermes' EBITDA averaged around $84.1 million, with its median value being $87.2 million (2025).
  • As far as peak fluctuations go, Alkermes' EBITDA crashed by 6,840.90% in 2022, and later soared by 834.04% in 2023.
  • Over the past 5 years, Alkermes' EBITDA (Quarterly) stood at -$379,000 in 2021, then tumbled by 6,840.90% to -$26.3 million in 2022, then soared by 539.99% to $115.7 million in 2023, then climbed by 24.51% to $144.1 million in 2024, then decreased by 13.79% to $83.1 million in 2025.
  • Its EBITDA was $83.1 million in Q3 2025, compared to $87.2 million in Q2 2025 and $23.0 million in Q1 2025.